The efficacy and safety of monopolar radiofrequency for treatment of enlarged pores in Asia

Phase 4

Recruiting

• Conditions: Patients with visible enlarged pores; monopolar radiofrequency, enlarged pores

• Registration Number: TCTR20220213001
• Lead Sponsor: Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-02-13
• Study Completion: 2022-06-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

1. aged 18-60 years
2. were diagnosed with enlarged pores by two dermatologists

Exclusion Criteria

1. Patients who are pregnant, lactating, and postpartum within 1 year 2. Patients who taking oral isotretinoin
3. Patients with other skin diseases, or having infection at the area of face
4. Immunocompromised patients
5. Patients with hypertrophic scar or keloid
6. Patients with history of Cushing syndrome or Ehlers-Danlos syndrome
7. Patients with cancers or skin cancers
8. Patients with mental disorders

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pore sizes by Antera Baseline, 1, 2, 4, 7 months Antera,Pore sizes by ImageJ Baseline, 1, 2, 4, 7 months ImageJ

Secondary Outcome Measures

Name	Time	Method
Sebum level Baseline, 1, 2, 4, 7 months Sebumeter,Safety Baseline, 1, 2, 4, 7 months Adverse event,Physician improvement scale Baseline, 1, 2, 4, 7 months percent improvement,Patient improvement scale Baseline, 1, 2, 4, 7 months percent improvement